Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial

Autor: Bennouna, Jaafar, Girard, Nicolas, Audigier-Valette, Clarisse, le Thuaut, Aurélie, Gervais, Radj, Masson, Philippe, Marcq, Marie, Molinier, Olivier, Cortot, Alexis, Debieuvre, Didier, Cadranel, Jacques, Lena, Hervé, Moro-Sibilot, Denis, Chouaid, Christos, Mennecier, Bertrand, Urban, Thierry, Sagan, Christine, Perrier, Ludivine, Barlesi, Fabrice, Denis, Marc G.
Zdroj: In Clinical Lung Cancer January 2020 21(1):e10-e14
Databáze: ScienceDirect